Your browser doesn't support javascript.
loading
Long-term efficacy and safety of chemotherapy-free first-line iodine-131-rituximab radioimmunotherapy of follicular lymphoma.
Kesavan, Murali; Zammar, Ghassan; McQuillan, James T; Macdonald, William B G; Turner, J Harvey; McQuillan, Andrew D.
Affiliation
  • Kesavan M; School of Medicine, The University of Western Australia, Perth, Australia.
  • Zammar G; Department of Haematology, Fiona Stanley Hospital, Perth, Australia.
  • McQuillan JT; School of Medicine, University of Notre Dame, Fremantle, Australia.
  • Macdonald WBG; Department of Molecular Imaging and Therapy, Fiona Stanley Hospital, Perth, Australia.
  • Turner JH; School of Medicine, The University of Western Australia, Perth, Australia.
  • McQuillan AD; School of Medicine, University of Notre Dame, Fremantle, Australia.
Br J Haematol ; 196(1): 237-241, 2022 01.
Article in En | MEDLINE | ID: mdl-34368952
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Follicular / Radioimmunotherapy / Rituximab / Iodine Radioisotopes Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2022 Document type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Follicular / Radioimmunotherapy / Rituximab / Iodine Radioisotopes Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2022 Document type: Article Affiliation country: Australia